The Deficiency Letter provided that, in accordance with Nasdaq Listing Rule 5810(c)(3)(A), Mynaric has 180 calendar days, or until July 22, 2025 (the "Compliance Period"), to regain compliance ...

NEW YORK, June 22, 2023 /PRNewswire/ -- On June 14, 2023, Etao International Co., Ltd. (the "Company") received a bid price deficiency letter from The Nasdaq Stock Market, LLC ("Nasdaq") notifying ...

Under the Nasdaq Listing Rule 5810(c)(2)(F)(i), the Company has until July 2, 2025 (that is, 60 calendar days from the date of the Deficiency Letter) to submit to Nasdaq a plan (the "Compliance ...